Cart
sales@molnova.com
Udenafil
CAS No. 268203-93-6
Udenafil( DA-8159 )
Catalog No. M13819 CAS No. 268203-93-6
A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 215 | Get Quote |
|
| 50MG | 345 | Get Quote |
|
| 100MG | 503 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameUdenafil
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
-
DescriptionA potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.Sexual Dysfunction Approved(In Vitro):Udenafil is an oral PDE5 inhibitor. Udenafil significantly increases cAMP and cGMP levels and are more highly distributed in the prostate than plasma.
-
In VitroUdenafil is an oral PDE5 inhibitor. Udenafil significantly increases cAMP and cGMP levels and are more highly distributed in the prostate than plasma.
-
In Vivo——
-
SynonymsDA-8159
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaEndocrinology
-
IndicationSexual Dysfunction
Chemical Information
-
CAS Number268203-93-6
-
Formula Weight516.6561
-
Molecular FormulaC25H36N6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33 mg/mL
-
SMILESO=S(C1=CC=C(OCCC)C(C(NC2=C3N(C)N=C2CCC)=NC3=O)=C1)(NCCC4N(C)CCC4)=O
-
Chemical NameBenzenesulfonamide, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Salem EA, et al. Curr Opin Investig Drugs. 2006 Jul;7(7):661-9.
2. Lee CH, et al. J Sex Med. 2010 Jul;7(7):2564-71.
3. Kang HE, et al. Br J Pharmacol. 2009 Mar;156(6):1009-18.
molnova catalog
related products
-
Anagrelide
Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor.
-
Mardepodect
A potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
-
Tofimilast
Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.
